• Loading stock data…

Addex Announces Participation in the 22nd Bio€quity Europe Conference

Last Updated on May 13, 2022 by GlobeNewsWire

Geneva, Switzerland, May 13, 2022 Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, and Dr. Robert Lütjens, Head of Discovery – Biology, will be attending 22nd Bio€quity Europe Conference taking place May 16 – 18, 2022, in Milan, Italy.




Print Friendly, PDF & Email
Spread the word

Reader Interactions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: